Abstract
Neuronal nuclei (NeuN) is a well-recognized “marker” that is detected exclusively in post-mitotic neurons and was initially identified through an immunological screen to produce neuron-specific antibodies. Immunostaining evidence indicates that NeuN is distributed in the nuclei of mature neurons in nearly all parts of the vertebrate nervous system. NeuN is highly conserved among species and is stably expressed during specific stages of development. Therefore, NeuN has been considered to be a reliable marker of mature neurons for the past two decades. However, this role has been challenged by recent studies indicating that NeuN staining is variable and even absent during certain diseases and specific physiological states. More importantly, despite the widespread use of the anti-NeuN antibody, the natural identity of the NeuN protein remained elusive for 17 years. NeuN was recently eventually identified as an epitope of Rbfox3, which is a novel member of the Rbfox1 family of splicing factors. This identification might provide a novel perspective on NeuN expression during both physiological and pathological conditions. This review summarizes the current progress on the biochemical identity and biological significance of NeuN and recommends caution when applying NeuN immunoreactivity as a definitive marker of mature neurons in certain diseases and specific physiological states.
Similar content being viewed by others
References
Mullen RJ, Buck CR, Smith AM (1992) NeuN, a neuronal specific nuclear protein in vertebrates. Development 116(1):201–211
Huttner HB, Bergmann O, Salehpour M, Racz A, Tatarishvili J, Lindgren E, Csonka T, Csiba L et al (2014) The age and genomic integrity of neurons after cortical stroke in humans. Nat Neurosci 17(6):801–803. doi:10.1038/nn.3706
Maxeiner S, Glassmann A, Kao HT, Schilling K (2014) The molecular basis of the specificity and cross-reactivity of the NeuN epitope of the neuron-specific splicing regulator, Rbfox3. Histochem Cell Biol 141(1):43–55. doi:10.1007/s00418-013-1159-9
Soylemezoglu F, Onder S, Tezel GG, Berker M (2003) Neuronal nuclear antigen (NeuN): a new tool in the diagnosis of central neurocytoma. Pathol Res Pract 199(7):463–468
Sarnat HB, Nochlin D, Born DE (1998) Neuronal nuclear antigen (NeuN): a marker of neuronal maturation in early human fetal nervous system. Brain Dev 20(2):88–94
Wolf HK, Buslei R, Schmidt-Kastner R, Schmidt-Kastner PK, Pietsch T, Wiestler OD, Blumcke I (1996) NeuN: a useful neuronal marker for diagnostic histopathology. J Histochem Cytochem 44(10):1167–1171
Preusser M, Laggner U, Haberler C, Heinzl H, Budka H, Hainfellner JA (2006) Comparative analysis of NeuN immunoreactivity in primary brain tumours: conclusions for rational use in diagnostic histopathology. Histopathology 48(4):438–444. doi:10.1111/j.1365-2559.2006.02359.x
Shen CC, Yang YC, Chiao MT, Cheng WY, Ko JL, Tsuei YS (2010) Characterization of Endogenous Neural Progenitor Cells after Experimental Ischemic Stroke. Curr Neurovasc Res
Davoli MA, Fourtounis J, Tam J, Xanthoudakis S, Nicholson D, Robertson GS, Ng GY, Xu D (2002) Immunohistochemical and biochemical assessment of caspase-3 activation and DNA fragmentation following transient focal ischemia in the rat. Neuroscience 115(1):125–136
Sugawara T, Lewen A, Noshita N, Gasche Y, Chan PH (2002) Effects of global ischemia duration on neuronal, astroglial, oligodendroglial, and microglial reactions in the vulnerable hippocampal CA1 subregion in rats. J Neurotrauma 19(1):85–98. doi:10.1089/089771502753460268
Safford KM, Safford SD, Gimble JM, Shetty AK, Rice HE (2004) Characterization of neuronal/glial differentiation of murine adipose-derived adult stromal cells. Exp Neurol 187(2):319–328. doi:10.1016/j.expneurol.2004.01.027
Long X, Olszewski M, Huang W, Kletzel M (2005) Neural cell differentiation in vitro from adult human bone marrow mesenchymal stem cells. Stem Cells Dev 14(1):65–69. doi:10.1089/scd.2005.14.65
Lind D, Franken S, Kappler J, Jankowski J, Schilling K (2005) Characterization of the neuronal marker NeuN as a multiply phosphorylated antigen with discrete subcellular localization. J Neurosci Res 79(3):295–302. doi:10.1002/jnr.20354
Kim KK, Adelstein RS, Kawamoto S (2009) Identification of neuronal nuclei (NeuN) as Fox-3, a new member of the Fox-1 gene family of splicing factors. J Biol Chem 284(45):31052–31061. doi:10.1074/jbc.M109.052969
Sievers F, Wilm A, Dineen D, Gibson TJ, Karplus K, Li W, Lopez R, McWilliam H et al (2011) Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol Syst Biol 7:539. doi:10.1038/msb.2011.75
Damianov A, Black DL (2010) Autoregulation of Fox protein expression to produce dominant negative splicing factors. RNA 16(2):405–416. doi:10.1261/rna.1838210
Stuurman N, Meijne AM, van der Pol AJ, de Jong L, van Driel R, van Renswoude J (1990) The nuclear matrix from cells of different origin. Evidence for a common set of matrix proteins. J Biol Chem 265(10):5460–5465
Fey EG, Penman S (1988) Nuclear matrix proteins reflect cell type of origin in cultured human cells. Proc Natl Acad Sci U S A 85(1):121–125
Dent MA, Segura-Anaya E, Alva-Medina J, Aranda-Anzaldo A (2010) NeuN/Fox-3 is an intrinsic component of the neuronal nuclear matrix. FEBS Lett 584(13):2767–2771. doi:10.1016/j.febslet.2010.04.073
Jangi M, Boutz PL, Paul P, Sharp PA (2014) Rbfox2 controls autoregulation in RNA-binding protein networks. Genes Dev 28(6):637–651. doi:10.1101/gad.235770.113
Gehman LT, Stoilov P, Maguire J, Damianov A, Lin CH, Shiue L, Ares M Jr, Mody I et al (2011) The splicing regulator Rbfox1 (A2BP1) controls neuronal excitation in the mammalian brain. Nat Genet 43(7):706–711. doi:10.1038/ng.841
Kuroyanagi H (2009) Fox-1 family of RNA-binding proteins. Cell Mol Life Sci : CMLS 66(24):3895–3907. doi:10.1007/s00018-009-0120-5
Tang ZZ, Zheng S, Nikolic J, Black DL (2009) Developmental control of CaV1.2 L-type calcium channel splicing by Fox proteins. Mol Cell Biol 29(17):4757–4765. doi:10.1128/MCB. 00608-09
Dredge BK, Jensen KB (2011) NeuN/Rbfox3 nuclear and cytoplasmic isoforms differentially regulate alternative splicing and nonsense-mediated decay of Rbfox2. PLoS One 6(6):e21585. doi:10.1371/journal.pone.0021585
Xie J (2014) Differential evolution of signal-responsive RNA elements and upstream factors that control alternative splicing. Cell Mol Life Sci : CMLS. doi:10.1007/s00018-014-1688-y
Korner M, Miller LJ (2009) Alternative splicing of pre-mRNA in cancer: focus on G protein-coupled peptide hormone receptors. Am J Pathol 175(2):461–472. doi:10.2353/ajpath.2009.081135
Kim KK, Kim YC, Adelstein RS, Kawamoto S (2011) Fox-3 and PSF interact to activate neural cell-specific alternative splicing. Nucleic Acids Res 39(8):3064–3078. doi:10.1093/nar/gkq1221
McManus CJ, Graveley BR (2011) RNA structure and the mechanisms of alternative splicing. Curr Opin Genet Dev 21(4):373–379. doi:10.1016/j.gde.2011.04.001
Kornblihtt AR, Schor IE, Allo M, Dujardin G, Petrillo E, Munoz MJ (2013) Alternative splicing: a pivotal step between eukaryotic transcription and translation. Nat Rev Mol Cell Biol 14(3):153–165. doi:10.1038/nrm3525
Zheng S, Black DL (2013) Alternative pre-mRNA splicing in neurons: growing up and extending its reach. Trends Genet : TIG 29(8):442–448. doi:10.1016/j.tig.2013.04.003
Chih B, Gollan L, Scheiffele P (2006) Alternative splicing controls selective trans-synaptic interactions of the neuroligin-neurexin complex. Neuron 51(2):171–178. doi:10.1016/j.neuron.2006.06.005
Dredge BK, Polydorides AD, Darnell RB (2001) The splice of life: alternative splicing and neurological disease. Nat Rev Neurosci 2(1):43–50. doi:10.1038/35049061
Charizanis K, Lee KY, Batra R, Goodwin M, Zhang C, Yuan Y, Shiue L, Cline M et al (2012) Muscleblind-like 2-mediated alternative splicing in the developing brain and dysregulation in myotonic dystrophy. Neuron 75(3):437–450. doi:10.1016/j.neuron.2012.05.029
Yeo G, Holste D, Kreiman G, Burge CB (2004) Variation in alternative splicing across human tissues. Genome Biol 5(10):R74. doi:10.1186/gb-2004-5-10-r74
Kim KK, Nam J, Mukouyama YS, Kawamoto S (2013) Rbfox3-regulated alternative splicing of Numb promotes neuronal differentiation during development. J Cell Biol 200(4):443–458. doi:10.1083/jcb.201206146
Kornack DR, Rakic P (1999) Continuation of neurogenesis in the hippocampus of the adult macaque monkey. Proc Natl Acad Sci U S A 96(10):5768–5773
Van Nassauw L, Wu M, De Jonge F, Adriaensen D, Timmermans JP (2005) Cytoplasmic, but not nuclear, expression of the neuronal nuclei (NeuN) antibody is an exclusive feature of Dogiel type II neurons in the guinea-pig gastrointestinal tract. Histochem Cell Biol 124(5):369–377. doi:10.1007/s00418-005-0019-7
Weyer A, Schilling K (2003) Developmental and cell type-specific expression of the neuronal marker NeuN in the murine cerebellum. J Neurosci Res 73(3):400–409. doi:10.1002/jnr.10655
Morin LP, Hefton S, Studholme KM (2011) Neurons identified by NeuN/Fox-3 immunoreactivity have a novel distribution in the hamster and mouse suprachiasmatic nucleus. Brain Res 1421:44–51. doi:10.1016/j.brainres.2011.09.015
Portiansky EL, Barbeito CG, Gimeno EJ, Zuccolilli GO, Goya RG (2006) Loss of NeuN immunoreactivity in rat spinal cord neurons during aging. Exp Neurol 202(2):519–521. doi:10.1016/j.expneurol.2006.07.014
Kumar SS, Buckmaster PS (2007) Neuron-specific nuclear antigen NeuN is not detectable in gerbil subtantia nigra pars reticulata. Brain Res 1142:54–60. doi:10.1016/j.brainres.2007.01.027
Brazelton TR, Rossi FM, Keshet GI, Blau HM (2000) From marrow to brain: expression of neuronal phenotypes in adult mice. Science 290(5497):1775–1779
Goetz AK, Scheffler B, Chen HX, Wang S, Suslov O, Xiang H, Brustle O, Roper SN et al (2006) Temporally restricted substrate interactions direct fate and specification of neural precursors derived from embryonic stem cells. Proc Natl Acad Sci U S A 103(29):11063–11068. doi:10.1073/pnas.0510926103
Rosser AE, Tyers P, ter Borg M, Dunnett SB, Svendsen CN (1997) Co-expression of MAP-2 and GFAP in cells developing from rat EGF responsive precursor cells. Brain Res Dev Brain Res 98(2):291–295
Johnson GV, Jope RS (1992) The role of microtubule-associated protein 2 (MAP-2) in neuronal growth, plasticity, and degeneration. J Neurosci Res 33(4):505–512. doi:10.1002/jnr.490330402
Wharton SB, Chan KK, Whittle IR (2002) Microtubule-associated protein 2 (MAP-2) is expressed in low and high grade diffuse astrocytomas. J Clin Neurosci : Off J Neurosurgical Soc Australasia 9(2):165–169. doi:10.1054/jocn.2001.1055
Shafit-Zagardo B, Kalcheva N (1998) Making sense of the multiple MAP-2 transcripts and their role in the neuron. Mol Neurobiol 16(2):149–162. doi:10.1007/BF02740642
Cronberg T, Rundgren M, Westhall E, Englund E, Siemund R, Rosen I, Widner H, Friberg H (2011) Neuron-specific enolase correlates with other prognostic markers after cardiac arrest. Neurology 77(7):623–630. doi:10.1212/WNL.0b013e31822a276d
Haimoto H, Takahashi Y, Koshikawa T, Nagura H, Kato K (1985) Immunohistochemical localization of gamma-enolase in normal human tissues other than nervous and neuroendocrine tissues. Lab Investig: J Technical Methods Pathol 52(3):257–263
Lawson SN, Harper AA, Harper EI, Garson JA, Anderton BH (1984) A monoclonal antibody against neurofilament protein specifically labels a subpopulation of rat sensory neurones. J Comp Neurol 228(2):263–272. doi:10.1002/cne.902280211
Lawson SN, Waddell PJ (1991) Soma neurofilament immunoreactivity is related to cell size and fibre conduction velocity in rat primary sensory neurons. J Physiol 435:41–63
Voelker CC, Garin N, Taylor JS, Gahwiler BH, Hornung JP, Molnar Z (2004) Selective neurofilament (SMI-32, FNP-7 and N200) expression in subpopulations of layer V pyramidal neurons in vivo and in vitro. Cereb Cortex 14(11):1276–1286. doi:10.1093/cercor/bhh089
Gould VE, Lee I, Wiedenmann B, Moll R, Chejfec G, Franke WW (1986) Synaptophysin: a novel marker for neurons, certain neuroendocrine cells, and their neoplasms. Hum Pathol 17(10):979–983
Kepes JJ, Collins J (1999) Choroid plexus epithelium (normal and neoplastic) expresses synaptophysin. A potentially useful aid in differentiating carcinoma of the choroid plexus from metastatic papillary carcinomas. J Neuropathol Exp Neurol 58(4):398–401
Sarnat HB, Flores-Sarnat L, Trevenen CL (2010) Synaptophysin immunoreactivity in the human hippocampus and neocortex from 6 to 41 weeks of gestation. J Neuropathol Exp Neurol 69(3):234–245. doi:10.1097/NEN.0b013e3181d0151f
Lee VM, Otvos L Jr, Carden MJ, Hollosi M, Dietzschold B, Lazzarini RA (1988) Identification of the major multiphosphorylation site in mammalian neurofilaments. Proc Natl Acad Sci U S A 85(6):1998–2002
Ouda L, Druga R, Syka J (2012) Distribution of SMI-32-immunoreactive neurons in the central auditory system of the rat. Brain Struct Funct 217(1):19–36. doi:10.1007/s00429-011-0329-6
Beyer K, Ariza A (2013) alpha-Synuclein posttranslational modification and alternative splicing as a trigger for neurodegeneration. Mol Neurobiol 47(2):509–524. doi:10.1007/s12035-012-8330-5
Cooper TA, Wan L, Dreyfuss G (2009) RNA and disease. Cell 136(4):777–793. doi:10.1016/j.cell.2009.02.011
Elia J, Glessner JT, Wang K, Takahashi N, Shtir CJ, Hadley D, Sleiman PM, Zhang H et al (2012) Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorder. Nat Genet 44(1):78–84. doi:10.1038/ng.1013
Lee JA, Tang ZZ, Black DL (2009) An inducible change in Fox-1/A2BP1 splicing modulates the alternative splicing of downstream neuronal target exons. Genes Dev 23(19):2284–2293. doi:10.1101/gad.1837009
Bill BR, Lowe JK, Dybuncio CT, Fogel BL (2013) Orchestration of neurodevelopmental programs by RBFOX1: implications for autism spectrum disorder. Int Rev Neurobiol 113:251–267. doi:10.1016/B978-0-12-418700-9.00008-3
O’Brien JE, Drews VL, Jones JM, Dugas JC, Barres BA, Meisler MH (2012) Rbfox proteins regulate alternative splicing of neuronal sodium channel SCN8A. Mol Cell Neurosci 49(2):120–126. doi:10.1016/j.mcn.2011.10.005
Fogel BL, Wexler E, Wahnich A, Friedrich T, Vijayendran C, Gao F, Parikshak N, Konopka G et al (2012) RBFOX1 regulates both splicing and transcriptional networks in human neuronal development. Hum Mol Genet 21(19):4171–4186. doi:10.1093/hmg/dds240
Lal D, Reinthaler EM, Altmuller J, Toliat MR, Thiele H, Nurnberg P, Lerche H, Hahn A et al (2013) RBFOX1 and RBFOX3 mutations in rolandic epilepsy. PLoS One 8(9):e73323. doi:10.1371/journal.pone.0073323
Vandeweyer G, Kooy RF (2009) Balanced translocations in mental retardation. Hum Genet 126(1):133–147. doi:10.1007/s00439-009-0661-6
Utami KH, Hillmer AM, Aksoy I, Chew EG, Teo AS, Zhang Z, Lee CW, Chen PJ et al (2014) Detection of chromosomal breakpoints in patients with developmental delay and speech disorders. PLoS One 9(6):e90852. doi:10.1371/journal.pone.0090852
Cooper GM, Coe BP, Girirajan S, Rosenfeld JA, Vu TH, Baker C, Williams C, Stalker H et al (2011) A copy number variation morbidity map of developmental delay. Nat Genet 43(9):838–846. doi:10.1038/ng.909
Li Y, Chopp M, Chen J, Wang L, Gautam SC, Xu YX, Zhang Z (2000) Intrastriatal transplantation of bone marrow nonhematopoietic cells improves functional recovery after stroke in adult mice. J Cereb Blood Flow Metab 20(9):1311–1319. doi:10.1097/00004647-200009000-00006
Toda H, Takahashi J, Iwakami N, Kimura T, Hoki S, Mozumi-Kitamura K, Ono S, Hashimoto N (2001) Grafting neural stem cells improved the impaired spatial recognition in ischemic rats. Neurosci Lett 316(1):9–12
Unal-Cevik I, Kilinc M, Gursoy-Ozdemir Y, Gurer G, Dalkara T (2004) Loss of NeuN immunoreactivity after cerebral ischemia does not indicate neuronal cell loss: a cautionary note. Brain Res 1015(1–2):169–174. doi:10.1016/j.brainres.2004.04.032
Hartmann A, Hunot S, Michel PP, Muriel MP, Vyas S, Faucheux BA, Mouatt-Prigent A, Turmel H et al (2000) Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson’s disease. Proc Natl Acad Sci U S A 97(6):2875–2880. doi:10.1073/pnas.040556597
Arenas E, Trupp M, Akerud P, Ibanez CF (1995) GDNF prevents degeneration and promotes the phenotype of brain noradrenergic neurons in vivo. Neuron 15(6):1465–1473
Patil DA, Patil VA, Bari SB, Surana SJ, Patil PO (2014) Animal Models for Parkinson’s Disease. CNS & neurological disorders drug targets
Mount MP, Lira A, Grimes D, Smith PD, Faucher S, Slack R, Anisman H, Hayley S et al (2007) Involvement of interferon-gamma in microglial-mediated loss of dopaminergic neurons. J Neurosci 27(12):3328–3337. doi:10.1523/JNEUROSCI. 5321-06.2007
Lee Y, Dawson VL, Dawson TM (2012) Animal models of Parkinson’s disease: vertebrate genetics. Cold Spring Harbor perspectives in medicine 2 (10). doi:10.1101/cshperspect.a009324
Baquet ZC, Bickford PC, Jones KR (2005) Brain-derived neurotrophic factor is required for the establishment of the proper number of dopaminergic neurons in the substantia nigra pars compacta. J Neurosci 25(26):6251–6259. doi:10.1523/JNEUROSCI. 4601-04.2005
Novikova L, Garris BL, Garris DR, Lau YS (2006) Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson’s disease. Neuroscience 140(1):67–76. doi:10.1016/j.neuroscience.2006.02.007
Zhu C, Vourc’h P, Fernagut PO, Fleming SM, Lacan S, Dicarlo CD, Seaman RL, Chesselet MF (2004) Variable effects of chronic subcutaneous administration of rotenone on striatal histology. J Comp Neurol 478(4):418–426. doi:10.1002/cne.20305
Cannon JR, Greenamyre JT (2009) NeuN is not a reliable marker of dopamine neurons in rat substantia nigra. Neurosci Lett 464(1):14–17. doi:10.1016/j.neulet.2009.08.023
Lavezzi AM, Corna MF, Matturri L (2013) Neuronal nuclear antigen (NeuN): a useful marker of neuronal immaturity in sudden unexplained perinatal death. J Neurol Sci 329(1–2):45–50. doi:10.1016/j.jns.2013.03.012
Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, Leblanc S, Corkran SH, Duarte NA et al (2011) HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirology 17(1):3–16. doi:10.1007/s13365-010-0006-1
Foley JM, Wright MJ, Gooding AL, Ettenhofer M, Kim M, Choi M, Castellon SA, Sadek J et al (2011) Operationalization of the updated diagnostic algorithm for classifying HIV-related cognitive impairment and dementia. Int Psychogeriatr / IPA 23(5):835–843. doi:10.1017/S1041610210002085
Gannon P, Khan MZ, Kolson DL (2011) Current understanding of HIV-associated neurocognitive disorders pathogenesis. Curr Opin Neurol 24(3):275–283. doi:10.1097/WCO.0b013e32834695fb
Ellis R, Langford D, Masliah E (2007) HIV and antiretroviral therapy in the brain: neuronal injury and repair. Nat Rev Neurosci 8(1):33–44. doi:10.1038/nrn2040
Lucas CH, Calvez M, Babu R, Brown A (2014) Altered subcellular localization of the NeuN/Rbfox3 RNA splicing factor in HIV-associated neurocognitive disorders (HAND). Neurosci Lett 558:97–102. doi:10.1016/j.neulet.2013.10.037
Orlova KA, Crino PB (2010) The tuberous sclerosis complex. Ann N Y Acad Sci 1184:87–105. doi:10.1111/j.1749-6632.2009.05117.x
Zhang CQ, Shu HF, Yin Q, An N, Xu SL, Yin JB, Song YC, Liu SY et al (2012) Expression and cellular distribution of vascular endothelial growth factor-C system in cortical tubers of the tuberous sclerosis complex. Brain Pathol 22(2):205–218. doi:10.1111/j.1750-3639.2011.00519.x
Sugimoto T, Xiao C, Ichikawa H (1998) Neonatal primary neuronal death induced by capsaicin and axotomy involves an apoptotic mechanism. Brain Res 807(1–2):147–154
McPhail LT, McBride CB, McGraw J, Steeves JD, Tetzlaff W (2004) Axotomy abolishes NeuN expression in facial but not rubrospinal neurons. Exp Neurol 185(1):182–190
Benn SC, Woolf CJ (2004) Adult neuron survival strategies–slamming on the brakes. Nat Rev Neurosci 5(9):686–700. doi:10.1038/nrn1477
Collombet JM, Masqueliez C, Four E, Burckhart MF, Bernabe D, Baubichon D, Lallement G (2006) Early reduction of NeuN antigenicity induced by soman poisoning in mice can be used to predict delayed neuronal degeneration in the hippocampus. Neurosci Lett 398(3):337–342. doi:10.1016/j.neulet.2006.01.029
Wu KL, Li YQ, Tabassum A, Lu WY, Aubert I, Wong CS (2010) Loss of Neuronal Protein Expression in Mouse Hippocampus After Irradiation. J Neuropathol Exp Neurol 69(3):272–280. doi:10.1097/NEN.0b013e3181d1afe4
Darlington PJ, Goldman JS, Cui QL, Antel JP, Kennedy TE (2008) Widespread immunoreactivity for neuronal nuclei in cultured human and rodent astrocytes. J Neurochem 104(5):1201–1209. doi:10.1111/j.1471-4159.2007.05043.x
Polydorides AD, Okano HJ, Yang YY, Stefani G, Darnell RB (2000) A brain-enriched polypyrimidine tract-binding protein antagonizes the ability of Nova to regulate neuron-specific alternative splicing. Proc Natl Acad Sci U S A 97(12):6350–6355. doi:10.1073/pnas.110128397
Pascale A, Gusev PA, Amadio M, Dottorini T, Govoni S, Alkon DL, Quattrone A (2004) Increase of the RNA-binding protein HuD and posttranscriptional up-regulation of the GAP-43 gene during spatial memory. Proc Natl Acad Sci U S A 101(5):1217–1222. doi:10.1073/pnas.0307674100
Acknowledgments
We would like to thank Dr. Kimberly Yasutis for proofreading and offering corrections and suggestions regarding the manuscript. This work was supported by grants from the National Natural Science Foundation of China (No. 81100891, No. 81471226) and the Natural Science Foundation Project of CQ (No. CSTC 2012 jjB10019).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Duan, W., Zhang, YP., Hou, Z. et al. Novel Insights into NeuN: from Neuronal Marker to Splicing Regulator. Mol Neurobiol 53, 1637–1647 (2016). https://doi.org/10.1007/s12035-015-9122-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12035-015-9122-5